000 | 01208 a2200337 4500 | ||
---|---|---|---|
005 | 20250518040933.0 | ||
264 | 0 | _c20200402 | |
008 | 202004s 0 0 eng d | ||
022 | _a1473-5857 | ||
024 | 7 |
_a10.1097/YIC.0000000000000270 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMena, Cristián I | |
245 | 0 | 0 |
_aClozapine-associated neutropenia in Latin America: incidence report of 5380 Chilean users. _h[electronic resource] |
260 |
_bInternational clinical psychopharmacology _c09 2019 |
||
300 |
_a257-263 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aChile _xepidemiology |
650 | 0 | 4 |
_aClozapine _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeutropenia _xchemically induced |
700 | 1 | _aNachar, Rubén A | |
700 | 1 | _aCrossley, Nicolás A | |
700 | 1 | _aGonzález-Valderrama, Alfonso A | |
773 | 0 |
_tInternational clinical psychopharmacology _gvol. 34 _gno. 5 _gp. 257-263 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/YIC.0000000000000270 _zAvailable from publisher's website |
999 |
_c29696261 _d29696261 |